ADvantage Therapeutics, Inc. — Form D
ADvantage Therapeutics, Inc. of Miami, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-24. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-06-24
- Form: D
- Accession: 0001869338-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2021-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-404212
Issuer
- Name: ADvantage Therapeutics, Inc.
- CIK: 0001869338
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 195 NW 40th Street, Miami, FL, 33140
- Phone: 630-886-7345
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Walter B Schmidt | Director | Miami, FL |
| Agustin Fernandez Santana III | Director | Miami, FL |
| Agustin Fernandez Santana III | Executive Officer | Miami, FL |
| Jeffrey B Madden | Director | Miami, FL |
| Jeffrey B Madden | Executive Officer | Miami, FL |
| David B Buchsbaum | Executive Officer | Miami, FL |
| Frank B Mattner | Director | Miami, FL |
| James B O'Neill | Director | Miami, FL |
Other filings by this issuer (3)
More